These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18793032)

  • 1. Multiple sclerosis in the UK: service use, costs, quality of life and disability.
    McCrone P; Heslin M; Knapp M; Bull P; Thompson A
    Pharmacoeconomics; 2008; 26(10):847-60. PubMed ID: 18793032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and quality of life of multiple sclerosis in the United Kingdom.
    Kobelt G; Berg J; Lindgren P; Kerrigan J; Russell N; Nixon R
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S96-104. PubMed ID: 17310341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and quality of life of multiple sclerosis in Sweden.
    Berg J; Lindgren P; Fredrikson S; Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Societal costs of multiple sclerosis in Ireland.
    Carney P; O'Boyle D; Larkin A; McGuigan C; O'Rourke K
    J Med Econ; 2018 May; 21(5):425-437. PubMed ID: 29320900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US.
    Jones E; Pike J; Marshall T; Ye X
    BMC Health Serv Res; 2016 Jul; 16():294. PubMed ID: 27443278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and quality of life for patients with multiple sclerosis in Belgium.
    Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of a multiple sclerosis relapse: the patient's perspective.
    Oleen-Burkey M; Castelli-Haley J; Lage MJ; Johnson KP
    Patient; 2012; 5(1):57-69. PubMed ID: 22217263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and quality of life of multiple sclerosis in Italy.
    Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and quality of life of multiple sclerosis in Germany.
    Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health status and costs of ambulatory patients with multiple sclerosis in Hungary.
    Péntek M; Gulácsi L; Rózsa C; Simó M; Iljicsov A; Komoly S; Brodszky V
    Ideggyogy Sz; 2012 Sep; 65(9-10):316-24. PubMed ID: 23126217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and quality of life of multiple sclerosis in Spain.
    Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability.
    Casado V; Martínez-Yélamos S; Martínez-Yélamos A; Carmona O; Alonso L; Romero L; Moral E; Gubieras L; Arbizu T
    BMC Health Serv Res; 2006 Nov; 6():143. PubMed ID: 17078879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of multiple sclerosis phenotypes on burden of disease in Finland.
    Purmonen T; Hakkarainen T; Tervomaa M; Ruutiainen J
    J Med Econ; 2020 Feb; 23(2):156-165. PubMed ID: 31617776
    [No Abstract]   [Full Text] [Related]  

  • 17. New insights into the burden and costs of multiple sclerosis in Europe: Results for the United Kingdom.
    Thompson A; Kobelt G; Berg J; Capsa D; Eriksson J; Miller D;
    Mult Scler; 2017 Aug; 23(2_suppl):204-216. PubMed ID: 28643587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands.
    Karampampa K; Gustavsson A; van Munster ET; Hupperts RM; Sanders EA; Mostert J; Sinnige OL; de Graaf J; Pop P; Miltenburger C; Groot MT; Relleke M; van der Hel WS
    J Med Econ; 2013 Jul; 16(7):939-50. PubMed ID: 23692584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
    da Silva NL; Takemoto MLS; Damasceno A; Fragoso YD; Finkelsztejn A; Becker J; Gonçalves MVM; Tilbery C; de Oliveira EML; Callegaro D; Boulos FC
    BMC Health Serv Res; 2016 Mar; 16():102. PubMed ID: 27009599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
    Ruutiainen J; Viita AM; Hahl J; Sundell J; Nissinen H
    J Med Econ; 2016; 19(1):21-33. PubMed ID: 26360615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.